Does cyclophosphamide benefit relapsing thrombotic thrombocytopenic purpura?

Journal of Association of Physicians of India

Volumn 50, Issue 11, 2002, Pages 1440-1442

  Agarwal, V ^a   Sharma, B L ^a   Aggarwal, Amita ^a   Misra, R ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; CYCLOPHOSPHAMIDE;

ADULT; ARTICLE; CASE REPORT; DIFFERENTIAL DIAGNOSIS; HUMAN; MALE; MULTIMODALITY CANCER THERAPY; PLASMAPHERESIS; RECURRENT DISEASE; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADULT; ANTINEOPLASTIC AGENTS, ALKYLATING; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DIAGNOSIS, DIFFERENTIAL; HUMANS; MALE; PLASMA EXCHANGE; PURPURA, THROMBOTIC THROMBOCYTOPENIC; RECURRENCE;

EID: 0037608756     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Byrnes JJ, Khurana M. Treatment of thrombotic thrombocytopenic purpura with plasma. N Engl J Med 1977;297:1386-9.
2. Rock G, Shumak KH, Sutton DM, Buskard NA, Nair RC. Cryosupernatant as a replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura. Members of the Canadian Apheresis Group. Br J Haematol 1996;94:383-6.
3. Bell WR. Thrombotic thrombocytopenic purpura / hemolytic uremic syndrome relapse: frequency, pathogenesis, and meaning. Semin Hematol 1997;34:134-9.
4. Perez-Sanchez I, Antigua J, Pintado T. Use of cyclophosphamide in the treatment of thrombotic thrombocytopenic purpura complicating systemic lupus erythematosus: report of two cases. Ann Hematol 1999;78:285-7.
5. Bird JM, Cummins D, Machin SJ. Cyclophosphamide for chronic relapsing thrombotic thrombocytopenic purpura. Lancet 1990;336:565-6.
6. Tsai HM, Lian EC. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 1998;339:1585-94.